This article is more than 5 years old. Information may no longer be current.

Perimetry device to detect, manage AMD to launch in U.S. in fall

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

DUBLIN, Calif. — Carl Zeiss Meditec plans to introduce a perimetry device for the detection and management of age-related macular degeneration to the U.S. market this fall and Europe and Asia “sometime afterwards,” according to a press release.

According to the company, clinical studies showed the machine to be more than twice as likely to detect the presence of age-related macular degeneration as the current standard diagnostic, the Amsler grid. This device uses hyperacuity to “painlessly and non-invasively detect the retinal lesions from AMD” that cause central vision loss, according to Carl Zeiss Meditec.

Tel Aviv-based Notal Vision developed the technology.